Element Capital Management LLC Ligand Pharmaceuticals Inc Transaction History

Element Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$107.38 - $129.34 $344,797 - $415,310	-3,211 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$105.93 - $142.47 $76,481 - $102,863	722 Added 29.01%	3,211 $404,000
Q4 2018 Feb 13, 2019	SELL	$128.36 - $272.13 $38,764 - $82,183	-302 Reduced 10.82%	2,489 $338,000
Q3 2018 Nov 14, 2018	BUY	$211.18 - $274.49 $229,763 - $298,645	1,088 Added 63.89%	2,791 $766,000
Q2 2018 Aug 14, 2018	SELL	$150.77 - $207.98 $11,609 - $16,014	-77 Reduced 4.33%	1,703 $353,000
Q1 2018 May 15, 2018	BUY	$138.63 - $182.62 $246,761 - $325,063	1,780 New	1,780 $294,000

249

17.7M

61K

7.8K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.91B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Element Capital Management LLC with notifications on news.